{"entity":{"id":"aura-biosciences","kind":"company","name":"Aura Biosciences","aka":[],"tldr":"Aura Biosciences is a United States-based biotechnology company running 2 late-stage cancer trials of AU-011 in melanoma and uveal melanoma.","summary":"Aura Biosciences, based in Boston, MA, the United States, is a biotechnology company. Aura Biosciences is a clinical-stage biotechnology company developing targeted oncology therapies for ocular cancers using its proprietary Virus-Like Drug Conjugate (VDC) technology. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing AU-011 in melanoma and uveal melanoma. The largest, NCT06007690 (A Phase 3 Randomised, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma), plans to enrol 108 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.aurabiosciences.com"},{"label":"ClinicalTrials.gov: trials led by Aura Biosciences","url":"https://clinicaltrials.gov/search?lead=Aura%20Biosciences"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["melanoma","uveal-melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06643884","nct06007690"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Boston, MA","country":"US","companyType":"biotech","website":"https://www.aurabiosciences.com","stage":"public","investors":[],"funding":[]},"route":"/companies/aura-biosciences/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"uveal-melanoma","kind":"cancer","name":"Uveal melanoma","route":"/cancers/uveal-melanoma/"}],"trial":[{"id":"nct06007690","kind":"trial","name":"A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma","route":"/trials/nct06007690/"},{"id":"nct06643884","kind":"trial","name":"Suprachoroidal Administration in Subjects With Metastases to the Choroid","route":"/trials/nct06643884/"}]}}